Your Health, We Care
Rezurock has been approved in multiple countries for the treatment of cGVHD. In Europe, multiple studies have confirmed the efficacy and safety of Besudil Mesylate in the treatment of cGVHD.
Future research will further explore the efficacy and safety of rezurock in patients with different subtypes of cGVHD, as well as the possibility of combination therapy.
